Jim Datin

Jim Datin

Vorstandsvorsitzender bei
BioAgilytix Europe GmbH
63 Jahre
Health Technology
Finance
Technology Services

Profil

Mr. Jim A. Datin is an Operating Partner at GHO Capital Partners LLP, a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at The North Carolina Biotechnology Center, BALX Holdings LLC, Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by OraSure Technologies, Inc., an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Celerant Consulting, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Aktive Positionen von Jim Datin

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.01.2017
Vorstandsvorsitzender -
Vorstandsvorsitzender -
Private Equity Investor 01.01.2023

Ehemalige bekannte Positionen von Jim Datin

UnternehmenPositionEnde
ORASURE TECHNOLOGIES, INC. Direktor/Vorstandsmitglied 01.06.2024
Vorstandsvorsitzender 16.06.2022
QUANTUM BIOPHARMA LTD. Direktor/Vorstandsmitglied 30.04.2021
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jim Datin im Detail an

Ausbildung von Jim Datin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

70

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Finance

Technology Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Technology Services

Miscellaneous

Technology Services

Finance

Finance

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Finance

Health Technology

Health Technology

Commercial Services

- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT